Angiotensin-converting enzyme inhibitors reduce hemoglobin concentrations, hematocrit, and serum erythropoietin levels in renal transplant recipients without posttransplant erythrocytosis

Transplant Proc. 2001 Feb-Mar;33(1-2):2038-40. doi: 10.1016/s0041-1345(00)02780-9.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Analysis of Variance
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology*
  • Erythropoietin / blood*
  • Female
  • Hematocrit
  • Hemoglobins / drug effects*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Kidney Transplantation*
  • Male
  • Middle Aged
  • Polycythemia / blood*
  • Postoperative Complications / blood*
  • Retrospective Studies

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Hemoglobins
  • Immunosuppressive Agents
  • Erythropoietin